Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Collegium Pharma (COLL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 494,314
  • Shares Outstanding, K 33,220
  • Annual Sales, $ 28,480 K
  • Annual Income, $ -74,870 K
  • 36-Month Beta 0.39
  • Price/Sales 16.57
  • Price/Cash Flow N/A
  • Price/Book 5.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.35
  • Number of Estimates 4
  • High Estimate -0.28
  • Low Estimate -0.40
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.00 +12.00%
on 09/18/18
17.52 -10.50%
on 08/29/18
-0.87 (-5.26%)
since 08/20/18
3-Month
14.00 +12.00%
on 09/18/18
28.69 -45.35%
on 06/21/18
-12.61 (-44.57%)
since 06/20/18
52-Week
9.01 +74.03%
on 10/31/17
29.90 -47.56%
on 03/09/18
+6.24 (+66.10%)
since 09/20/17

Most Recent Stories

More News
Collegium Pharma Shares Down 35.6% Since SmarTrend's Sell Call (COLL)

SmarTrend identified a Downtrend for Collegium Pharma (NASDAQ:COLL) on July 6th, 2018 at $21.99. In approximately 2 months, Collegium Pharma has returned 35.61% as of today's recent price of $14.16.

COLL : 15.68 (+5.38%)
Akorn Inc has the Best Relative Performance in the Pharmaceuticals Industry (AKRX , DERM , COLL , PCRX , MDCO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

COLL : 15.68 (+5.38%)
DERM : 10.92 (+0.92%)
AKRX : 13.22 (-1.20%)
Downtrend Call Working As Collegium Pharma Stock Falls 27.0% (COLL)

SmarTrend identified a Downtrend for Collegium Pharma (NASDAQ:COLL) on July 6th, 2018 at $21.99. In approximately 2 months, Collegium Pharma has returned 27.01% as of today's recent price of $16.05.

COLL : 15.68 (+5.38%)
Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting

Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it has supported the following poster presentations on tapentadol (Nucynta(R) and Nucynta(R) ER), at PAINWeek 2018 on September 6th in...

COLL : 15.68 (+5.38%)
Relatively Good Performance Detected in Shares of Lannett Co Inc in the Pharmaceuticals Industry (LCI , COLL , NKTR , PRTK , OMER )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

COLL : 15.68 (+5.38%)
LCI : 5.50 (+13.40%)
NKTR : 58.44 (+3.09%)
Relatively Good Performance Detected in Shares of Intersect Ent In in the Pharmaceuticals Industry (XENT , COLL , MYL , PCRX , MNK )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

MYL : 38.73 (+1.28%)
COLL : 15.68 (+5.38%)
XENT : 29.15 (-0.68%)
17.9% Return Seen to Date on SmarTrend Collegium Pharma Call (COLL)

SmarTrend identified a Downtrend for Collegium Pharma (NASDAQ:COLL) on July 6th, 2018 at $21.99. In approximately 1 month, Collegium Pharma has returned 17.87% as of today's recent price of $18.06.

COLL : 15.68 (+5.38%)
Collegium Pharmaceutical (COLL) Reports Q2 Loss, Tops Revenue Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 65.91% and 4.06%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

COLL : 15.68 (+5.38%)
Collegium Reports Second Quarter Financial Results and Provides Corporate Update

-- Xtampza ER prescriptions grew by 23% in the second quarter of 2018

COLL : 15.68 (+5.38%)
Collegium Pharmaceutical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Collegium Pharmaceutical, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30 PM Eastern...

COLL : 15.68 (+5.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade COLL with:

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

2nd Resistance Point 16.27
1st Resistance Point 15.97
Last Price 15.68
1st Support Level 15.16
2nd Support Level 14.65

See More

52-Week High 29.90
Fibonacci 61.8% 21.92
Fibonacci 50% 19.45
Fibonacci 38.2% 16.99
Last Price 15.68
52-Week Low 9.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar